MENU
VITL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vital Farms (VITL) Earnings Date & Reports

Vital Farms Inc is an ethical food company... Show more

A.I. Advisor
published Earnings

VITL is expected to report earnings to fall 229.33% to 19 cents per share on March 11

Vital Farms VITL Stock Earnings Reports
Q4'26
Est.
$0.19
Q3'26
Missed
by $0.02
Q2'26
Missed
by $0.03
Q1'26
Missed
by $0.19
Q4'25
Missed
by $0.04
The last earnings report on November 03 showed earnings per share of -15 cents, missing the estimate of -12 cents. With 824.23K shares outstanding, the current market capitalization sits at 408.71M.
A.I.Advisor
Nov 03, 2026

Vital Farms (VITL) Earnings Preview: A Crucial Test for the Egg Brand's Turnaround

Key Takeaways

  • Vital Farms (NASDAQ: VITL), the leading U.S. pasture-raised egg brand, is expected to report third-quarter 2026 results in early November — its first quarter after management called Q2 2026 the financial low point of the year.
  • Investors will focus on whether net revenue returns to sequential growth and whether gross margin rebounds from Q2 2026's depressed 6.6% level, versus 38.9% a year earlier.
  • The company's recovery plan centers on narrowing price gaps to branded competitors, right-sizing egg supply through farmer contract amendments, and reducing overhead costs.
  • Management reaffirmed full-year 2026 guidance of $775 million to $800 million in net revenue and $0 to $10 million in Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization).
  • For more coverage of the ticker, explore its Major News, Today's Price Move, Price Targets, and Forecast pages.
  • Explore Trending AI Robots to discover additional market ideas and automated strategies.

Earnings Context and Why It Matters

Vital Farms enters its third-quarter 2026 earnings report at an inflection point. After a record fiscal 2025 — when revenue rose 25.3% to $759.4 million — the company has been hit in 2026 by an industry-wide oversupply of eggs and widening price gaps against branded competitors. The result was a $31.1 million net loss in Q2 2026 and an Adjusted EBITDA loss of $26.6 million. Management has insisted that quarter marked the financial trough and that the second half will look "fundamentally different." This report is therefore a credibility test: investors want evidence that the turnaround is working before pricing in a durable recovery.

Earnings Expectations

Vital Farms does not issue formal quarterly guidance, but management has telegraphed a clear sequential trajectory. Following Q2 2026's 10.1% revenue decline to $166.0 million, executives expect the second half to reflect a return to positive shell-egg volume growth and a sales mix shift back toward higher-margin retail channels.

Key metrics in focus include the average retail price gap versus branded competitors — narrowed to roughly $2.36 in Q2 from $2.51 in Q1, with a target of $1 to $2 — and distribution gains, measured through total distribution points (TDPs), a retail metric capturing store presence and shelf space. Management expects TDPs to reach 170 to 175 in the fourth quarter, up from 148.7 year-to-date through Q2.

On profitability, the company has said it anticipates exiting the fourth quarter at a gross-margin run rate of approximately 30%, versus 6.6% in Q2. The full-year outlook — $775 million to $800 million in net revenue and $0 to $10 million in Adjusted EBITDA — implies a meaningful rebound in the back half of 2026.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Vital Farms, the AI Screener offers a structured way to identify comparable opportunities across the consumer staples and food sectors.

Market Reaction and Investor Sentiment

Sentiment heading into the report is cautious. Vital Farms shares have fallen sharply in 2026 as the egg oversupply compressed margins, erasing much of the valuation premium the stock carried during its 2025 growth run. The market appears to be pricing in a gradual, rather than immediate, recovery.

Key risk factors include the pace of price-gap normalization, whether the broader shell-egg category stabilizes, and execution on the wind-down of the company's butter business, which generated $7.8 million in exit-related costs in Q2. Investors will also weigh whether new distribution commitments translate into actual velocity gains and whether supply-management costs continue to fade. A print showing clear sequential improvement in revenue, gross margin, and Adjusted EBITDA could reinforce the turnaround narrative, while another weak quarter would raise fresh questions about the durability of the recovery.

Forward Outlook and Key Factors to Monitor

Following the earnings report, the most important signal will be management's commentary on the trajectory of gross margin. Vital Farms has guided toward a roughly 30% gross-margin run rate exiting the fourth quarter, so investors will watch whether third-quarter results put that target within reach.

Distribution momentum is another key variable. New placements, including a 24-count package at select retailers, are expected to support volume recovery in the second half. Progress in total distribution points — and whether those gains convert into sustained household acquisition — will help gauge the strength of demand.

Supply discipline will also matter. With farmer contract amendments now in place, the company aims to manage the temporary supply-demand imbalance by reducing egg production rather than routing excess eggs to the lower-priced breaker channel. Success here should ease the cost pressure that drove the Q2 loss.

Finally, investors should monitor liquidity and capital spending. Vital Farms recently secured $185 million in new credit facilities and slowed capital expenditures, including pausing construction at its planned Vital Crossroads facility, to align capacity additions with demand. How management frames its 2027 setup — and whether it reaffirms or adjusts full-year guidance — will likely shape the post-earnings reaction.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a distributer of pasture-raised shell eggs, pasture-raised butter and other products

Industry AgriculturalCommoditiesMilling

Industry
N/A
Address
3601 South Congress Avenue
Phone
+1 877 455-3063
Employees
739
Web
https://www.vitalfarms.com